mianserin has been researched along with Day Blindness in 1 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We aimed to evaluate predictors and mediators of enhancing effect of adjunctive mirtazapine on cognition in schizophrenia." | 9.17 | Predictors and mediators of add-on mirtazapine-induced cognitive enhancement in schizophrenia--a path model investigation. ( Burkin, M; Chukhin, E; Joffe, G; Joffe, M; Stenberg, JH; Terevnikov, V; Tiihonen, J, 2013) |
| "We aimed to evaluate predictors and mediators of enhancing effect of adjunctive mirtazapine on cognition in schizophrenia." | 5.17 | Predictors and mediators of add-on mirtazapine-induced cognitive enhancement in schizophrenia--a path model investigation. ( Burkin, M; Chukhin, E; Joffe, G; Joffe, M; Stenberg, JH; Terevnikov, V; Tiihonen, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stenberg, JH | 1 |
| Terevnikov, V | 1 |
| Joffe, M | 1 |
| Tiihonen, J | 1 |
| Chukhin, E | 1 |
| Burkin, M | 1 |
| Joffe, G | 1 |
1 trial available for mianserin and Day Blindness
| Article | Year |
|---|---|
Predictors and mediators of add-on mirtazapine-induced cognitive enhancement in schizophrenia--a path model investigation.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Antipsychotic Agents; Cognition; Cognition Disorders | 2013 |